| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer
|
Justice, Amy C.
|
|
|
7 |
4 |
p. 923-932
|
artikel
|
| 2 |
Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
|
Billon, Emilien
|
|
|
7 |
4 |
p. 742-750
|
artikel
|
| 3 |
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma
|
Msaouel, Pavlos
|
|
|
7 |
4 |
p. 933-943
|
artikel
|
| 4 |
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
|
Kotecha, Ritesh R.
|
|
|
7 |
4 |
p. 804-811
|
artikel
|
| 5 |
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group
|
Pellegrino, Francesco
|
|
|
7 |
4 |
p. 888-896
|
artikel
|
| 6 |
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
|
Slevin, Finbar
|
|
|
7 |
4 |
p. 677-696
|
artikel
|
| 7 |
Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer
|
Kanayama, Mayuko
|
|
|
7 |
4 |
p. 751-759
|
artikel
|
| 8 |
Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis
|
Gomez-Veiga, Francisco
|
|
|
7 |
4 |
p. 860-869
|
artikel
|
| 9 |
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis
|
Matsukawa, Akihiro
|
|
|
7 |
4 |
p. 697-704
|
artikel
|
| 10 |
Comparison of Regional Saturation Biopsy, Targeted Biopsy, and Systematic Biopsy in Patients with Prostate-specific Antigen Levels of 4–20 ng/ml: A Prospective, Single-center, Randomized Controlled Trial
|
Jiang, Xingkang
|
|
|
7 |
4 |
p. 944-953
|
artikel
|
| 11 |
Contents
|
|
|
|
7 |
4 |
p. iii-viii
|
artikel
|
| 12 |
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer
|
Orme, Jacob J.
|
|
|
7 |
4 |
p. 877-887
|
artikel
|
| 13 |
Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?
|
Sathianathen, Niranjan J.
|
|
|
7 |
4 |
p. 870-876
|
artikel
|
| 14 |
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients
|
Jiménez, Natalia
|
|
|
7 |
4 |
p. 954-964
|
artikel
|
| 15 |
Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds
|
Kawada, Tatsushi
|
|
|
7 |
4 |
p. 649-662
|
artikel
|
| 16 |
Early Identification of Patients at Risk of Cabazitaxel-induced Severe Neutropenia
|
Agema, Bram C.
|
|
|
7 |
4 |
p. 786-793
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
7 |
4 |
p. i-ii
|
artikel
|
| 18 |
From Screening to Mortality Reduction: An Overview of Empirical Data on the Patient Journey in European Randomized Study of Screening for Prostate Cancer Rotterdam After 21 Years of Follow-up and a Reflection on Quality of Life
|
Hogenhout, Renée
|
|
|
7 |
4 |
p. 713-720
|
artikel
|
| 19 |
Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort
|
Beeren, Ivy
|
|
|
7 |
4 |
p. 829-837
|
artikel
|
| 20 |
Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer
|
Ni, Xudong
|
|
|
7 |
4 |
p. 897-905
|
artikel
|
| 21 |
Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data
|
Figaroa, Orlane J.A.
|
|
|
7 |
4 |
p. 853-859
|
artikel
|
| 22 |
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer
|
Moore, Assaf
|
|
|
7 |
4 |
p. 812-820
|
artikel
|
| 23 |
Metastatic Organotropism Differential Treatment Response in Urothelial Carcinoma: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
|
Kardoust Parizi, Mehdi
|
|
|
7 |
4 |
p. 663-676
|
artikel
|
| 24 |
Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population
|
Stroomberg, Hein V.
|
|
|
7 |
4 |
p. 770-777
|
artikel
|
| 25 |
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study
|
Rajwa, Pawel
|
|
|
7 |
4 |
p. 721-734
|
artikel
|
| 26 |
Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years
|
Moen, Christian A.
|
|
|
7 |
4 |
p. 778-785
|
artikel
|
| 27 |
Positive Surgical Margins After Anterior Robot-assisted Radical Prostatectomy: Assessing the Learning Curve in a Multi-institutional Collaboration
|
Bravi, Carlo A.
|
|
|
7 |
4 |
p. 821-828
|
artikel
|
| 28 |
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer
|
Small, Eric J.
|
|
|
7 |
4 |
p. 844-852
|
artikel
|
| 29 |
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
|
Grivas, Petros
|
|
|
7 |
4 |
p. 914-922
|
artikel
|
| 30 |
Prognostic Significance of HER2 Expression in Patients with Bacillus Calmette-Guérin–exposed Non–muscle-invasive Bladder Cancer
|
Tan, Xingliang
|
|
|
7 |
4 |
p. 760-769
|
artikel
|
| 31 |
Prostate Cancer–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group
|
Falagario, Ugo Giovanni
|
|
|
7 |
4 |
p. 705-712
|
artikel
|
| 32 |
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
|
Gandhy, Shruti U.
|
|
|
7 |
4 |
p. 735-741
|
artikel
|
| 33 |
Re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508–515
|
Lombardo, Riccardo
|
|
|
7 |
4 |
p. 965-966
|
artikel
|
| 34 |
Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508–515
|
D'Andrea, David
|
|
|
7 |
4 |
p. 967-968
|
artikel
|
| 35 |
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
|
Tutrone, Ronald
|
|
|
7 |
4 |
p. 906-913
|
artikel
|
| 36 |
The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort
|
Shee, Kevin
|
|
|
7 |
4 |
p. 838-843
|
artikel
|
| 37 |
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer
|
Lin, John K.
|
|
|
7 |
4 |
p. 794-803
|
artikel
|
Tijdschrift beschrijving